In order to improve the quality of bovine serum production in China, the China Pharmaceutical Biotechnology Association has been carrying out industry self-discipline activities in the field of bovine serum production since 2003, organizing industry experts to conduct quality standard inspections on bovine serum production enterprises.

Guangzhou Ruite Biotechnology Co., Ltd. has successfully passed the certification for bovine serum production enterprises and obtained the "Certificate of Conformity for Bovine Serum Production Enterprises" and "Certificate of Conformity for Bovine Serum Production Quality Enterprises" in February 2018.

At the end of 2016, Ruite Biotechnology officially put into production its newly built bovine serum production base located in Mingzhu Industrial Park, Conghua District, Guangzhou. The production base covers a total area of 15000 square meters, with a purification workshop area of 3000 square meters. The batch production volume of bovine serum is 3000L, and the annual production scale exceeds 100000 liters, ranking among the leading positions in China.

In May 2017, Ruite Biotechnology joined the China Pharmaceutical Biotechnology Association. In October of the same year, Ruite Biotechnology, under the guidance of the China Pharmaceutical Biotechnology Association, underwent a two-day on-site audit by the expert group for the certification and audit of bovine serum production enterprises. In February 2018, Ruite Biotechnology successfully obtained the "Certificate of Conformity for Bovine Serum Production Enterprises" and the "Certificate of Conformity for Bovine Serum Production Quality Enterprises" issued by the China Pharmaceutical Biotechnology Association.

The acquisition of this certificate not only marks a perfect end to Ruite Biotechnology's 2017 annual closing work, but also opens a new door for entering the military vaccine market in 2018.

Since its establishment in 2003, Guangzhou Ruite Biotechnology Co., Ltd. has been focusing on the research and development of animal blood products. Its main products include animal serum, plasma, fetal bovine serum substitutes, high-purity low endotoxin bovine serum albumin, transferrin, fibronectin, etc. In 2016, the company built a new 15000 square meter production base in Conghua District, Guangzhou to expand production, with an overall investment of over 30 million yuan. The entire company has passed the ISO9001:2015 quality management system certification and has successively become a member of the China Pharmaceutical Biotechnology Association and the Guangdong Province Clinical In vitro Diagnostic Products (IVD) Professional Committee.

After 15 years of accumulation and refinement, Ruite Biotechnology is steadily walking on the path of rapid development, which is inseparable from the arduous efforts and hard work of Ruite people themselves, as well as the strong support and care of numerous partners and new and old customers.

Setting sail in 2018, Ruite Biotechnology - still your trusted partner!